Evidence map›Paper›PMID 41054706›Full record

ArticleOpen forum infectious diseases2025

Rebecca E Sell, Derek Juang, Paul Stark, Kathleen Jacobs, Alexandrea O Cronin, Sharon L Reed, Joshua Fierer

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Frontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rebecca E SellDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
Derek JuangDepartment of Medicine, University of California San Diego, San Diego, California, USA.
Paul StarkCardiothoracic Radiology, VA Medical Center San Diego, San Diego, California, USA.
Kathleen JacobsRadiology Service, VA Medical Center San Diego, San Diego, California, USA.
Alexandrea O CroninClinical Trials Office, Moores Cancer Center, University of California San Diego, San Diego, California, USA.
Sharon L ReedDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0001-7615-9366
Joshua FiererMedical Service, VA Medical Center San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0002-9230-5279

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: This retrospective cohort study was conducted in 3 hospitals in an urban region of Southern California. The sample included adult patients with empyema and pleural fluid cultures positive for 1 or more SAG microorganisms. We excluded patients with bronchopleural fistulas or lung abscess because SAG bacteria are known to be a cause of those infections and can breach the physical barrier of the visceral pleura. Results: Thirty-seven patients with SAG empyema were identified: 14 had had polymicrobial cultures including 1 or more species of SAG bacteria (pSAG) and 23 had pure cultures of SAG bacteria. The patients were mostly middle-aged men with comorbidities, some of which predispose to aspiration or the inability to clear aspirated secretions. The patients with pSAG empyema were more likely to have cancer and/or prior surgical disruption of the esophagus with resulting mediastinitis. Patients with SAG empyema were more likely to use substances such as alcohol, sedatives, and narcotics. All computed tomography (CT) scans were initially interpreted as atelectasis abutting the empyema, but 13 patients with SAG empyema had contrast-enhanced CT scans that were suitable for measuring Hounsfield units (HUs) in the areas of consolidation adjacent to the SAG empyema; these scans revealed that they all had pneumonia as the source of their empyema. The most common species isolated from the SAG cases was Conclusions: Community-acquired SAG empyema is a complication of unrecognized SAG pneumonia.

Indexed as

empyemaHounsfield unitspneumoniaStreptococcus anginosus group

Identifiers

PMID41054706
PMCPMC12497506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.